Aging and the Anticoagulant Response to Warfarin Therapy
- 1 June 1992
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 116 (11) , 901-904
- https://doi.org/10.7326/0003-4819-116-11-901
Abstract
▪ Objective: To assess the effect of aging on the anticoagulant response to warfarin. ▪ Design: Retrospective cohort study. ▪ Setting: A university hospital outpatient anticoagulation clinic. ▪ Patients: All patients (n = 530) monitored in the anticoagulation clinic over a 10-year period (1980 to 1990). The 530 study patients had a mean age of 61.5 (± 14.7) years (age range, 12 to 90 years). The patients were stratified into four age groups: younger than 50 years (n = 97); 50 to 59 years (n = 107); 60 to 69 years (n = 149); and 70 years or older (n = 177). ▪ Measurements: For each patient, a dose-adjusted mean prothrombin time ratio was calculated by dividing the mean prothrombin time ratio by the mean daily warfarin dose. ▪ Results: Older patients were more likely to be female (P < 0.001), to have more medical problems (P < 0.001), to be taking more medications (P < 0.001), and to weigh less than younger patients (P < 0.001). Across age groups, there were no significant differences in the use of medications that potentiated or inhibited the anticoagulant effects of warfarin. The prothrombin time ratio, when adjusted for dose, was significantly increased in older patients (P < 0.001). The increased anticoagulant response to warfarin seen with increasing patient age persisted even after simultaneously controlling for relevant demographic and clinical variables in a multivariate model. Other factors significantly associated with an increased sensitivity to warfarin included use of a medication with a potentiating interactive effect with warfarin, female gender, and overall medication use. Increased body weight and duration of warfarin use exceeding 6 months were found to be inversely related to anticoagulant response. ▪ Conclusion: The anticoagulant response to warfarin is exaggerated with advancing age. This finding emphasizes the need for close monitoring of older patients treated with warfarin therapy.Keywords
This publication has 24 references indexed in Scilit:
- Management of Drug Therapy in the ElderlyNew England Journal of Medicine, 1989
- Clinical Pharmacokinetics of the Third Generation CephalosporinsClinical Pharmacokinetics, 1985
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Resistance to Warfarin Due to Unrecognized Vitamin K SupplementationNew England Journal of Medicine, 1980
- Factors affecting warfarin requirementsEuropean Journal of Clinical Pharmacology, 1979
- Epidemiology of Venous ThromboembolismAnnals of Surgery, 1977
- Age as a determinant of sensitivity to warfarin.British Journal of Clinical Pharmacology, 1977
- Determinants of anticoagulant control in patients receiving warfarin.British Journal of Clinical Pharmacology, 1977
- Protein Intake and Serum Albumin Levels in the ElderlyGerontology, 1977